The dizziness AE is listed in the Patient Information Section of the Vascepa Package Insert. It's listed as a symptom that is commonly reported for A-Fib patients. So because there were report of Vascepa apparently causing A-Fib the patient they would possibly be a risk to experiencing dizziness. If a patient in the study did not report or experience A-Fib the dizziness AE would not be an issue. I went back and reviewed the entire PI.
News 
Market Data 
Discover 
